Patient
SITE002-0153
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE002 (USA) (Dr. Nolan)
consented 2026-03-04
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 1 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-02-28 (study day 169); relationship: NOT RELATED
Grade 1 Hypothyroidism — outcome: RECOVERED/RESOLVED; onset 2023-01-07 (study day 117); relationship: not assessed
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-12-26 (study day 105); relationship: not assessed
Grade 2 Hypothyroidism — outcome: RECOVERED/RESOLVED; onset 2022-12-17 (study day 96); relationship: not assessed
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-12-09 (study day 88); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.